Avenue Therapeutics, Inc. (ATXI)
0.54
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Avenue Therapeutics Enterprise Value : -0.1627M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | -0.1627M |
| September 04, 2026 | -0.148M |
| September 03, 2026 | -0.0639M |
| September 02, 2026 | -0.0639M |
| September 01, 2026 | -0.2286M |
| August 31, 2026 | -0.4527M |
| August 28, 2026 | -0.4527M |
| August 27, 2026 | -0.0408M |
| August 26, 2026 | -0.4592M |
| August 25, 2026 | -0.5911M |
| August 24, 2026 | -1.093M |
| August 21, 2026 | -1.093M |
| August 20, 2026 | -1.093M |
| August 19, 2026 | -1.093M |
| August 18, 2026 | -1.093M |
| August 17, 2026 | -1.093M |
| August 14, 2026 | -1.093M |
| August 13, 2026 | -1.017M |
| August 12, 2026 | -1.052M |
| August 11, 2026 | -1.101M |
| August 10, 2026 | -1.101M |
| August 07, 2026 | -1.101M |
| August 06, 2026 | -0.9519M |
| August 05, 2026 | -0.9519M |
| August 04, 2026 | -0.9519M |
| Date | Value |
|---|---|
| August 03, 2026 | -0.7188M |
| July 31, 2026 | -0.6645M |
| July 30, 2026 | -0.6645M |
| July 29, 2026 | -0.769M |
| July 28, 2026 | -0.9535M |
| July 27, 2026 | -0.9973M |
| July 24, 2026 | -1.034M |
| July 23, 2026 | -1.085M |
| July 22, 2026 | -1.052M |
| July 21, 2026 | -1.085M |
| July 20, 2026 | -1.118M |
| July 17, 2026 | -1.118M |
| July 16, 2026 | -1.118M |
| July 15, 2026 | -1.085M |
| July 14, 2026 | -1.085M |
| July 13, 2026 | -0.8916M |
| July 10, 2026 | -0.8916M |
| July 09, 2026 | -0.8916M |
| July 08, 2026 | -0.8546M |
| July 07, 2026 | -0.8546M |
| July 06, 2026 | -0.8546M |
| July 02, 2026 | -0.937M |
| July 01, 2026 | -1.019M |
| June 30, 2026 | -1.019M |
| June 29, 2026 | -1.494M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.848B |
| Corcept Therapeutics, Inc. | 12.00B |
| Veru, Inc. | 20.88M |
| Johnson & Johnson | 676.38B |
| Eli Lilly & Co. | 1.104T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.69M |
| Total Expenses (Quarterly) | 0.69M |
| EPS Diluted (Quarterly) | -0.2094 |
| Earnings Yield | -158.8% |
| Normalized Earnings Yield | -158.83 |